Navigation Links
Reportlinker Adds Pharmaceutical Key Trends 2011 Overview - Key strategic trends in the pharmaceutical industry

NEW YORK, June 14, 2011 /PRNewswire/ -- announces that a new market research report is available in its catalogue:

Pharmaceutical Key Trends 2011 Overview - Key strategic trends in the pharmaceutical industry


A number of factors have and will continue to impact pharmaceutical sales and profits going forward. As a result of rising healthcare costs, healthcare budgets are being stretched.

Healthcare payers are also feeling the impact of the global economic downturn.

As a result, payers are introducing a number of cost-containment strategies as well as tougher regulatory measures

Features and benefits

* An overview of drivers of rising healthcare costs

* Review the impact of the global economic downturn on the healthcare and the pharmaceutical industry

* Assess the growing cost-containment and regulatory pressures facing pharma

* An overview of the impact of the patent expiries on pharma together with the industry's responses


Aging populations, the growing prevalence of chronic disease, greater use of expensive treatments, and expanding public healthcare coverage are stretching existing healthcare resources. As a result of rising unemployment, healthcare payers are also feeling the impact of the global economic downturn through reduced funding via taxation.

In response, payers are introducing a number of cost-containment strategies, such as reducing healthcare budgets and implementing pricing and reimbursement cuts, as well as bolstering generic uptake. These measures, together with the increasingly tough regulatory environment, all have a negative impact on the pharmaceutical industry.

Branded pharmaceutical companies are set to lose approximately $100bn in sales due to the patent cliff and the resultant generic erosion of branded sales during 2010–15 in the seven major markets, while the industry is also feeling the effects of the recent global economic downturn both directly and indirectly.

Your key questions answered

* Evaluate factors driving healthcare costs in the developed and emerging markets, and how the economic downturn has impacted the healthcare landscape

* Gain insight into the impact that the patent cliff as well as growing use of biosimilars will have on branded pharma sales out to 2015

* Review the growing cost-containment and regulatory measures facing pharma, as well as the industry's response to grow profitability going forward

Executive Summary

Strategic scoping and focus

Key findings


Demographic trends in the major developed and emerging markets

Aging patient populations

Growing prevalence of chronic diseases

Greater use of expensive treatments – pharmaceutical expenditure is increasing in all markets

Expanding pubic healthcare coverage


Impact of the economic downturn on both developed and emerging markets

Growing uninsured population – US patients are less able to cover the costs of healthcare, including pharmaceuticals

Government strategies to cut the budget deficit target healthcare and pharmaceutical expenditure


Government strategies to contain healthcare and pharma costs

Healthcare spending has slowed in several markets as governments bring in austerity measures

Pricing and reimbursement cuts were key elements included in austerity measures in many developed markets

Regulatory changes have a largely negative impact on pharma

Healthcare systems globally are converging toward a similar model

Driving generic uptake will create further savings


The patent cliff represents a major resistor to branded pharma growth

Branded pharma set to lose $82bn due to the patent cliff

Biosimilar uptake is set to accelerate


Pharma innovates, diversifies, and contains cost in order to grow profits

Pharma's strategic responses to drive sales and profitability

Innovation – pharma sharpens its focus on secondary care indications through high value biologic therapies

Diversification – growth in global markets will more than offset sales decline in the US

Cost-cutting – pharma cuts cost to increase margins

The impact of pharma's strategic responses on forecast sales during 2010–15


Publications and online articles

Datamonitor reports and products


Exchange rates used in this report

To order this report:

Managed care Industry: Pharmaceutical Key Trends 2011 Overview - Key strategic trends in the pharmaceutical industry

Managed care Business News

More  Market Research Report

Check our  Company Profile, SWOT and Revenue Analysis!

Nicolas Bombourg
US: (805)652-2626
Intl: +1 805-652-2626

SOURCE Reportlinker
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Reportlinker Adds Distributor Analysis of the Pharmaceutical Industry in Key SADC Countries
2. Reportlinker Adds Global Electrophysiology Mapping and Ablation Devices Industry
3. Reportlinker Adds Middle East And Africa Neurology Devices Market Outlook to 2017
4. Reportlinker Adds South and Central America Dental Devices Market Outlook to 2017
5. Reportlinker Adds Middle East and Africa Dental Devices Market Outlook to 2017
6. Reportlinker Adds Asia-Pacific Markets for Patient Monitoring Devices 2011
7. Reportlinker Adds European Markets for Hearing Aids and Audiology Devices 2011
8. Reportlinker Adds Hip Replacement Implants - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017
9. Reportlinker Adds Middle East and Africa ENT Devices Market Outlook to 2017
10. Reportlinker Adds China Medical Devices Industry - A Market Snapshot and Key Company Profiles
11. Reportlinker Adds Neurostimulation Devices - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017
Post Your Comments:
(Date:11/30/2015)... CHICAGO , Nov. 30, 2015   Nuance ... The National Decision Support Company (NDSC) today ... support and collaboration capabilities that utilize the American College ... and healthcare provider organizations to comply with current ... --> --> By combining clinical ...
(Date:11/30/2015)... Nov. 30, 2015 Booth #4303 – The Imaging ... will exhibit a broader array of products in a new ... of North America in ... meeting will feature X-ray components "At the Heart of Imaging." ... of products from Varian,s Claymount brand, and computer-aided diagnostic software ...
(Date:11/30/2015)... -- Hanger, Inc. (NYSE: HGR ) (the "Company") today ... its previously announced consent solicitation (as amended and restated, ... amount 7⅛% Senior Notes due 2018 (the "Notes") to ... pursuant to the Consent Solicitation, (ii) the proposed increased ... date of the Consent Solicitation.    ...
Breaking Medicine Technology:
(Date:11/30/2015)... ... November 30, 2015 , ... ... last 15 years, announced today that Michigan-based Family Health Center (FHC) has selected ... over 45 years, FHC was awarded the largest Affordable Care Act grant for ...
(Date:11/30/2015)... Ill. (PRWEB) , ... November 30, 2015 , ... ... Decision Support Solutions, announced at the Radiology Society of North America (RSNA) annual ... have seen over 60% growth from 2014. Throughout 2015, the company has ...
(Date:11/30/2015)... , ... November 30, 2015 , ... ... publishing magazines and websites specializing in independent living, assisted living and all other ... and Alzheimer’s awareness and research remains a top priority. , ...
(Date:11/30/2015)... , ... November 30, 2015 ... ... is pleased to announce the speakers for “Value-Based Payer-Provider Partnerships: Three Case ... from three innovative value-based care arrangements: Essentia Health and UCare, MissionPoint Health ...
(Date:11/30/2015)... PA (PRWEB) , ... November 30, 2015 , ... ... software provider, has verified that their Vasont Universal Integrator (VUI) extension unites with ... creating, editing, and managing content as a continuous process with the latest release ...
Breaking Medicine News(10 mins):